These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10906923)

  • 1. Stuttering: an update for physicians.
    Costa D; Kroll R
    CMAJ; 2000 Jun; 162(13):1849-55. PubMed ID: 10906923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoxetine for persistent developmental stuttering.
    Kumar A; Balan S
    Clin Neuropharmacol; 2007; 30(1):58-9. PubMed ID: 17272973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severity of dysfluency correlates with basal ganglia activity in persistent developmental stuttering.
    Giraud AL; Neumann K; Bachoud-Levi AC; von Gudenberg AW; Euler HA; Lanfermann H; Preibisch C
    Brain Lang; 2008 Feb; 104(2):190-9. PubMed ID: 17531310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stuttering: an overview.
    Prasse JE; Kikano GE
    Am Fam Physician; 2008 May; 77(9):1271-6. PubMed ID: 18540491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Speech motor correlates of treatment-related changes in stuttering severity and speech naturalness.
    Tasko SM; McClean MD; Runyan CM
    J Commun Disord; 2007; 40(1):42-65. PubMed ID: 16765980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical plasticity associated with stuttering therapy.
    Neumann K; Preibisch C; Euler HA; von Gudenberg AW; Lanfermann H; Gall V; Giraud AL
    J Fluency Disord; 2005; 30(1):23-39. PubMed ID: 15769497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The road to efficient and effective stuttering management: information for physicians.
    Kalinowski J; Saltuklaroglu T
    Curr Med Res Opin; 2004 Apr; 20(4):509-15. PubMed ID: 15119988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal speech sound representation in persistent developmental stuttering.
    Corbera S; Corral MJ; Escera C; Idiazábal MA
    Neurology; 2005 Oct; 65(8):1246-52. PubMed ID: 16247052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stuttering: neuropsychiatric features measured by content analysis of speech and the effect of risperidone on stuttering severity.
    Maguire GA; Gottschalk LA; Riley GD; Franklin DL; Bechtel RJ; Ashurst J
    Compr Psychiatry; 1999; 40(4):308-14. PubMed ID: 10428191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental and persistent developmental stuttering: an overview for primary care physicians.
    Ashurst JV; Wasson MN
    J Am Osteopath Assoc; 2011 Oct; 111(10):576-80. PubMed ID: 22065298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stuttering may be a type of action dystonia.
    Kiziltan G; Akalin MA
    Mov Disord; 1996 May; 11(3):278-82. PubMed ID: 8723145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fluency shaping with surface electromyography: a pilot study].
    Furquim de Andrade CR; Sassi FC; Juste FS; Ercolin B
    Pro Fono; 2008; 20(2):129-32. PubMed ID: 18622522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Return of stuttering after stroke.
    Mouradian MS; Paslawski T; Shuaib A
    Brain Lang; 2000 Jun; 73(1):120-3. PubMed ID: 10872640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropharmacology of theophylline induced stuttering: the role of dopamine, adenosine and GABA.
    Movsessian P
    Med Hypotheses; 2005; 64(2):290-7. PubMed ID: 15607558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II clinical trial of self-imposed time-out treatment for stuttering in adults and adolescents.
    Hewat S; Onslow M; Packman A; O'Brian S
    Disabil Rehabil; 2006 Jan; 28(1):33-42. PubMed ID: 16393831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural anomaly and reorganization in speakers who stutter: a short-term intervention study.
    Lu C; Chen C; Peng D; You W; Zhang X; Ding G; Deng X; Yan Q; Howell P
    Neurology; 2012 Aug; 79(7):625-32. PubMed ID: 22875083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Conditions in stuttering. Results of an interdisciplinary study of 3- to 5-year-old children. Neurologic aspects].
    Mielke U
    Padiatr Grenzgeb; 1993; 31(4):237-43. PubMed ID: 8259317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stuttering.
    Rosenfield DB
    CRC Crit Rev Clin Neurobiol; 1984; 1(2):117-39. PubMed ID: 6400509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based treatment and stuttering--historical perspective.
    Prins D; Ingham RJ
    J Speech Lang Hear Res; 2009 Feb; 52(1):254-63. PubMed ID: 18695017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of self-generated synchronous and asynchronous visual speech feedback on overt stuttering frequency.
    Snyder GJ; Hough MS; Blanchet P; Ivy LJ; Waddell D
    J Commun Disord; 2009; 42(3):235-44. PubMed ID: 19304293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.